BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27181358)

  • 1. microRNA-328 inhibits cervical cancer cell proliferation and tumorigenesis by targeting TCF7L2.
    Wang X; Xia Y
    Biochem Biophys Res Commun; 2016 Jun; 475(2):169-75. PubMed ID: 27181358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of miR-212 targeting TCF7L2 on the proliferation and metastasis of cervical cancer.
    Zhou C; Tan DM; Chen L; Xu XY; Sun CC; Zong LJ; Han S; Zhang YZ
    Eur Rev Med Pharmacol Sci; 2017 Jan; 21(2):219-226. PubMed ID: 28165569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
    Luo M; Shen D; Zhou X; Chen X; Wang W
    Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-125a-5p modulates human cervical carcinoma proliferation and migration by targeting ABL2.
    Qin X; Wan Y; Wang S; Xue M
    Drug Des Devel Ther; 2016; 10():71-9. PubMed ID: 26766902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of microRNA-135b inhibited growth of cervical cancer cells by targeting FOXO1.
    Xu Y; Zhao S; Cui M; Wang Q
    Int J Clin Exp Pathol; 2015; 8(9):10294-304. PubMed ID: 26617737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-138 is a potential biomarker and tumor suppressor in human cervical carcinoma by reversely correlated with TCF3 gene.
    Li H; Sheng Y; Zhang Y; Gao N; Deng X; Sheng X
    Gynecol Oncol; 2017 Jun; 145(3):569-576. PubMed ID: 28385388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of forkhead box Q1 by microRNA-506 represses the proliferation and epithelial-mesenchymal transition of cervical cancer cells.
    Zhang M; Xu Q; Yan S; Li Z; Yan W; Jia X
    Oncol Rep; 2016 May; 35(5):3106-14. PubMed ID: 26935526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer.
    Xu J; Li Y; Wang F; Wang X; Cheng B; Ye F; Xie X; Zhou C; Lu W
    Oncogene; 2013 Feb; 32(8):976-87. PubMed ID: 22469983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-373 functions as an oncogene and targets YOD1 gene in cervical cancer.
    Wang LQ; Zhang Y; Yan H; Liu KJ; Zhang S
    Biochem Biophys Res Commun; 2015 Apr; 459(3):515-20. PubMed ID: 25747718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-20a promotes cervical cancer proliferation and metastasis in vitro and in vivo.
    Zhao S; Yao D; Chen J; Ding N; Ren F
    PLoS One; 2015; 10(3):e0120905. PubMed ID: 25803820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-141-3p fosters the growth, invasion, and tumorigenesis of cervical cancer cells by targeting FOXA2.
    Li JH; Zhang Z; Du MZ; Guan YC; Yao JN; Yu HY; Wang BJ; Wang XL; Wu SL; Li Z
    Arch Biochem Biophys; 2018 Nov; 657():23-30. PubMed ID: 30222949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-433 inhibits cervical cancer progression by directly targeting metadherin to regulate the AKT and β-catenin signalling pathways.
    Liang C; Ding J; Yang Y; Deng L; Li X
    Oncol Rep; 2017 Dec; 38(6):3639-3649. PubMed ID: 29130111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of miR-320 associated with cancer progression and cell apoptosis via targeting Mcl-1 in cervical cancer.
    Zhang T; Zou P; Wang T; Xiang J; Cheng J; Chen D; Zhou J
    Tumour Biol; 2016 Jul; 37(7):8931-40. PubMed ID: 26753959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-202 inhibits the progression of human cervical cancer through inhibition of cyclin D1.
    Yi Y; Li H; Lv Q; Wu K; Zhang W; Zhang J; Zhu D; Liu Q; Zhang W
    Oncotarget; 2016 Nov; 7(44):72067-72075. PubMed ID: 27732565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A.
    Wang N; Zhou Y; Zheng L; Li H
    Gynecol Oncol; 2014 Jul; 134(1):129-37. PubMed ID: 24793973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-22-3p Regulates Cell Proliferation and Inhibits Cell Apoptosis through Targeting the eIF4EBP3 Gene in Human Cervical Squamous Carcinoma Cells.
    Lv KT; Liu Z; Feng J; Zhao W; Hao T; Ding WY; Chu JP; Gao LJ
    Int J Med Sci; 2018; 15(2):142-152. PubMed ID: 29333098
    [No Abstract]   [Full Text] [Related]  

  • 17. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.
    Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
    Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-205 serves as a prognostic factor and suppresses proliferation and invasion by targeting insulin-like growth factor receptor 1 in human cervical cancer.
    Pang H; Yue X
    Tumour Biol; 2017 Jun; 39(6):1010428317701308. PubMed ID: 28651495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-133a inhibits cervical cancer growth by targeting EGFR.
    Song X; Shi B; Huang K; Zhang W
    Oncol Rep; 2015 Sep; 34(3):1573-80. PubMed ID: 26134491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis.
    He S; Liao B; Deng Y; Su C; Tuo J; Liu J; Yao S; Xu L
    BMC Cancer; 2017 Oct; 17(1):673. PubMed ID: 28978307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.